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Abstract-A design of boron neutron capture therapy for of cancer treatment in Indonesia. Boron Neutron Capture 
Therapy (BNCT) is an advanced form of radiotherapy technique that is potentially superior to all conventional techniques 
for cancer treatment, as it is targeted at killing individual cancerous cells with minimal damage to surrounding healthy cells. 
After decades of development, BNCT has reached clinical-trial stages in several countries, mainly for treating challenging 
cancers such as malignant brain tumors.  The Indonesian consortium of BNCT already developed of the design BNCT 
for many cases of type cancers using many neutron sources. The main objective of the Indonesian consortium BNCT are 
the development of BNCT technology package which consists of a non nuclear reactor neutron source based on cyclotron 
and compact neutron generator technique, advanced boron-carrying pharmaceutical, and user-friendly treatment platform 
with automatic operation and feedback system as well as commercialization of the BNCT though franchised network of 
BNCT clinics worldwide.  The Indonesian consortium BNCT will offering to participate in Boron carrier pharmaceuticals 
development and testing, development of cyclotron and compact neutron generators and provision of neutrons from the 
100 kW Kartini Research Reactor to guide and to validate compact neutron generator development. Studies were carried 
out to design a collimator which results in epithermal neutron beam for Boron Neutron Capture Therapy (BNCT) at the 
Kartini Research Reactor by means of Monte Carlo N-Particle 5 (MCNP5) codes. Reactor within 100 kW of output thermal 
power was used as the neutron source. The design criteria were based on the IAEA’s recommendation. All materials used 
were varied in size, according to the value of mean free path for each. Monte Carlo simulations indicated that by using 5 
cm thick of Ni as collimator wall, 60 cm thick of Al as moderator, 15 cm thick of 60Ni as filter, 1,5 cm thick of Bi as γ-ray 
shielding, 3 cm thick of 6Li
2
CO
3
-polyethylene as beam delimiter, with 3-5 cm varied aperture size, epithermal neutron 
beam with minimum flux of 7,8 x 108 n.cm-2.s-1, maximum fast neutron and γ-ray components of, respectively, 1,9 x 10-13 
Gy.cm2.n-1 and 1,8 x 10-13 Gy.cm2.n-1, maximum thermal neutron per epithermal neutron ratio of 0,009, and beam minimum 
directionality of 0,72, could be produced. The beam did not fully pass the IAEA’s criteria, since the epithermal neutron flux 
was still below the recommended value, 1,0 x 109 n.cm-2.s-1. Nonetheless, it was still usable with epithermal neutron flux 
exceeded 5 x 108 n.cm-2.s-1. When this collimator was surrounded by 8 cm thick of graphite, the characteristics of the beam 
became better that it passed all IAEA’s criteria with epithermal neutron flux up to 1,7 x 109 n.cm-2.s-1. it is still feasible for 
BNCT in vivo experiment and study of many cases cancer type i.e.; liver and lung curcinoma. In this case, thermal neutron 
produced by model of Collimated Thermal Column Kartini Research Nuclear Reactor, Yogyakarta. Sodium boroncaptate 
(BSH) was used as in this research. BSH had effected in liver for radiation quality factor as 0.8 in health tissue and 2.5 in 
cancer tissue.  Modelling organ and source used liver organ who contain of cancer tissue and research reactor. Variation of 
boron concentration was 20, 25, 30, 35, 40, 45, and 47 μg/g cancer. Output of MCNP calculation were neutron scattering 
dose, gamma ray dose and neutron flux from reactor. Given the advantages of low density owned by lungs, hence BNCT is a 
solid option that can be utilized to eradicate the cell cancer in lungs. Modelling organ and neutron source for lung carcinoma 
was used Compact Neutron Generator (CNG) by deuterium-tritium which was used is boronophenylalanine (BPA). The 
concentration of boron-10 compound was varied in the study; i.e. the variations were 20; 25; 30; 35; 40 and 45 µg.g-1 cancer 
tissues. Ideally, the primary dose which is solemnly expected to contribute in the therapy is alpha dose, but the secondary 
dose; i.e. neutron scattering dose, proton dose and gamma dose that are caused due to the interaction of thermal neutron with 
the spectra of tissue can not be simply omitted. Thus, the desired output of MCNPX; i.e. tally, were thermal and epithermal 
neutron flux, neutron and photon dose. The liver study variation of  boron concentration result dose rate to every variation 
were0,042; 0,050; 0,058; 0,067; 0,074; 0,082; 0,085 Gy/sec. Irradiation time who need to every concentration were 1194,687 
sec (19 min  54 sec);999,645 sec (16 min 39 sec); 858,746 sec (14 min 19 sec); 743,810 sec (12 min 24 sec); 675,156 sec 
(11 min 15 sec); 608,480 sec (10 min 8 sec); 585,807sec (9 min 45 sec). The lung carcinoma study variations of boron-10 
concentration in tissue resulted in the dose rate of each variables respectively were 0.003145, 0.003657, 0.00359, 0.00385, 
0.00438 and 0.00476 Gy.sec-1 . The irradiated time needed for therapy for each variables respectively were 375.34, 357.55, 
287.58, 284.95, 237.84 and 219.84 minutes. 
Keywords — liver, Lung carcinoma, Boron Neutron Capture Therapy, Compact DT Neutron generator.
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INTRODUCTION
Cancer was a leading cause of death 
worldwide, accounting for 7.6 million deaths 
(around 13% of all deaths) in 2008. Lung, 
stomach, liver, colon and breast cancer caused 
the most cancer deaths each year. Liver cancer 
was in third position (695.000 death) as cause 
of death after lung and stomach cancer [1].
Indonesia requires a technique of handling 
and treatment of cancer is safe and effective. 
Secure here means the destruction or adverse 
events received by healthy organs was minimal. 
The skin is the body part that is closest to the 
radiation source so that the dose received was 
also greater than in tumors of organs in the 
body. Due to these side effects, do not allow 
exposure only from one direction only. This 
side effect has been reduced by multiplying the 
direction of irradiation (radiation field) to more 
than one. The dose received by the skin surface 
will be less than using radiation field slightly 
but side effects such as the appearance of a 
blackish color of the skin is still there. Surface 
dose reduction by increasing the radiation field 
aims to secure critical organs around the area 
of irradiation. Therefore, until now the external 
radiation is used because it is still able to treat 
and control the growth of cancer cells. Effective 
means the dose received by the cancer cells as 
much as possible until adequate to treat and 
control the growth. Effective here cannot be 
separated from the safe limit [2].
In ensuring that there is cancer in the 
patient’s body controlled or killed, the need for 
determining the value of the collective radiation 
received by the cancer cells. Dose values 
are based on the value of the Linear Energy 
Transfer (LET) of each of the radiation used 
and the material traversed by the radiation. This 
value can be called absorbed dose. According 
to BAPETEN Decree number 4 in 2013, “The 
radiation dose is the amount of radiation 
contained in the radiation field or total radiation 
energy absorbed or received by the material in 
its path “. Calculation of dose can also be called 
dosimetry. Boron Neutron Capture Therapy 
was cancer therapy who used physics principle 
in nuclear reaction interaction. Interaction 
occurred when stable boron (boron-10) were 
irradiated by low energy neutron (thermal 
neutron). Main reaction was occurred in this 
therapy based on Equation (1) and (2) [3]. 
  (1)
  
                      (2)
In TRIGA MARK-II type research reactor 
in Yogyakarta, which has also been known 
as Kartini Research Reactor, the facility for 
BNCT is going to be built for an advanced 
study which uses tumour-injected animals as 
the object. The thermal column of this reactor 
is planned to be implanted with a device which 
is capable of narrowing the neutron beam, 
called as collimator. Due to the tendency of 
epithermal neutron beams usage for BNCT, the 
collimator must contains materials needed to 
produce epithermal neutron beam which fulfill 
some particular characteristics recommended 
by the International Atomic Energy Agency 
(IAEA). Thus, a proper collimator has to be 
designed. Liver cancer was malignant who 
located in liver. It had a primary tumor in liver 
and could be called by primary liver cancer or 
Hepatocellular Carcinoma (HCC). HCC had 
a different condition if liver cancer caused by 
metastatic from the cancer in other organ such as 
breast cancer, lung cancer or colon cancer. This 
condition called as Metastatic liver cancer [4].
Two boron compounds that have been 
used for BNCT is BSH (sodium Boroncaptate) 
and BPA (boron phenylalanine). Both of these 
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compounds have accumulated difference of 
place when inserted into the body. BSH will 
accumulate in the cell membrane while the 
BPA will accumulate in the nucleus of cells 
[5]. Liver was given an infusion sodium 
boroncaptate (BSH) by intracarotidly (i.c.) 
method. Intracarotidly is infusion of boron 
compound thoroughly internal artery in carotid 
gland. Carotid gland is artery who supply blood 
into head and neck. Liver was irradiated in 
nuclear reactor until the target get dose enough 
and did not get over dose in health tissue [3]. 
Concentration values  for the patients was 47 
ppm in tumor tissue ( CT patients ) and 8 ppm 
in healthy liver tissue ( CR patients ) . In rodents 
( rats ) , the peak concentration of boron - 10 in 
the liver occurs when two hours after injection 
into the body, Sodium boroncaptate (BSH) was 
used as in this research. BSH had effected in 
liver for radiation quality factor as 0.8 in health 
tissue and 2.5 in cancer tissue [6].
THEORY
Table 1 shows the beam cri ter ia 
recommended by the IAEA. The energy limits 
of 5 x 10-7, 0,01, and 20 MeV were used which, 
respectively, denoted the energy range for 
thermal, epithermal, and fast neutrons. In this 
table, Φ
epi
, Φ
th
, and J are epithermal neutron 
flux, thermal neutron flux, and neutron current, 
respectively. Moreover, 
f
 and 
γ
 stand for dose 
rates due to the fast neutrons and gamma rays.
Table 1. Beam criteria recommended by the IAEA [7]
Nomenclature Value
Φepi (n.cm-2.s-1)  > 1,0 x 109 
f
 / Φ
epi
 (Gy.cm2.n-1)
 < 2,0 x 10-13 
γ
 / Φ
epi
 (Gy.cm2.n-1)
 < 2,0 x 10-13 
Φ
th
 / Φ
epi
< 0,05 
J / Φ
epi
> 0,7 
Several experiences in designing 
collimator for BNCT have been conducted 
both based on the materials selection and the 
geometry optimisation. A collimator consists 
of 5 components: collimator wall, moderator, 
filter, γ-ray shielding, and aperture. 
Collimator wall should reflect neutrons 
back into the inner part of collimator. Suitable 
reflector materials for this are those with high 
scattering cross section and high atomic mass, 
such as Pb, Bi, PbF
2
, and Ni. Moderation of 
fast neutrons is best accomplished by low 
atomic mass materials. Suitable candidates 
are Al, C, S, Al
2
O
3
, AlF
3
, D
2
O, and (CF
2
)n. 
Materials such as Pb and Bi may be placed 
in the beam to reduce γ-rays. These will 
nonetheless reduce neutron beam intensity. 
For epithermal neutron beams, it is desirable to 
limit thermal and fast neutron contamination by 
filtering. Filter materials for thermal neutrons 
require 6Li, 10B or Cd. For filtering out the fast 
neutrons, 60Ni isotope can be placed. Aperture 
is a part of collimator which provides required 
cross section of the beam. This part is made 
of 6Li
2
CO
3
-polyethylene or B
4
C. Epithermal 
neutrons striking the wall of the collimator are 
thermalised and captured. James Michaelson 
(2003) used screening mammography to 
detect breast cancer. According to the result of 
the study, it was found that the size at which 
breast cancers become surely detectable was 
approximately 30 mm. Thus, 30 mm would be 
a convenient minimum aperture size for the 
collimator design [7,8,9]. 
BNCT is based on the reaction of low 
energy neutrons with boron-10 producing two 
high particles: a lithium-7 ion and an alpha 
particle. The cross section of the 10B(n,α)7Li 
reaction is very high: 3837 barn at thermal 
energies,and the Q-value is 2.790 MeV. With 
a probability of 94%, the reaction gives rise to 
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the Li ion in an excited state, which returns to 
its fundamental level with a gamma emission 
of 478 keV [10]. First of all, a boron-10 
carrying drug is injected into the blood. Then, 
a tumor accumulates the drug through the blood 
transportation system. Thereafter, the tumor is 
irradiated by a thermal neutron; i.e. E ≈ 0.025 
eV or an epithermal neutron; i.e. 1 eV < E < 10 
keV source. Finally, the boron-10 atoms inside 
the tumor capture the neutrons to produce highly 
energetic helium-4 nuclei; i.e., alpha particles 
and recoiling lithium-7 ions to kill the tumor 
cells [10].
Figure 1. Schematic of Boron-10 and neutron 
interaction [4].
There are three major components which 
are required in BNCT; i.e. boron compounds, 
neutron source and dosimetry of BNCT. Two 
typical boron compounds which are commonly 
used for BNCT are sodium borocaptate (BSH) 
and p-boronophenylalanine (BPA). Both are 
currently tested in on-going clinical trial since 
2011 and has been through pre-clinical trial 
notably in Brookhaven National Laboratory, 
USA. One of the compounds, BSH will not 
take up into normal brain cells because of 
the Blood Brain Barrier (BBB) effect. BBB 
is highly selective permeability barrier that 
separates the circulating blood from the brain 
extracellular fluid (BECF) in the central 
nervous system (CNS). Although BBB of 
tumor cell is damaged so that BSH is able to 
accumulate in tumor cell, especially around the 
cell membrane. The other boron compounds, 
BPA has different characteristic. Its chemical 
structure resembles tyrosine and dihydroxy-
phenylalanine (DOPA) which is the precursor 
of the melanin metabolism. Its characteristic 
makes BPA has inherent accumulation around 
the cell nucleus [7,8,9].
 There are 4 main doses that contribute 
in the treatment of BNCT: the boron dose from 
boron neutron capture reaction, the proton dose 
from nitrogen capture reaction, the neutron dose 
and the gamma dose. The primary dose is the 
dose of Lithium-7 and alpha with energy of 2,79 
MeV (6,1%) and 2,31 MeV (93,9%). Lithium-7 
produced from the decay reaction will back 
to the initial energy level and emit gamma 
(0,48MeV). The average energy produced from 
the interaction of the Boron-10 with thermal 
neutrons is 2,33 MeV.  The secondary dose 
comes from 3 interactions. Interaction between 
fast and thermal neutron with tissue commonly 
called neutron scattering. The calculated dose 
is the dose of neutron scattering due to the 
reaction between fast and thermal neutron with 
Hydrogen-1 nuclei. Protons are recoil product 
in the interaction. Gamma and hydrogen-2 
are produced from absorption reaction of the 
neutron interaction with hydrogen contained 
in the body tissues. Produced hydrogen-2 is an 
excited atom. hydrogen-2 production rate of 
thermal neutron interaction with hydrogen-1 
is proportional to the photon release rate with 
energy of 2,33 MeV.Nitrogen-14 has a fairly 
high mass fraction which is 4,5% of the tissue 
mass. Tissue irradiation by thermal neutron 
leads to interaction of thermal neutrons with 
nitrogen-14. This reaction produces carbon-14 
and proton with energy of 0,66 MeV. Carbon-
14 is a radioactive element with a long half-life 
which is 5730 years.
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METHOD
This study was conducted by doing 
simulations using MCNP5 program. It works 
based on the probability of interactions between 
radiations and materials which is derived from 
the microscopic cross sections. The probability is 
defined as the ratio of microscopic cross sections 
of interaction of interest per total microscopic 
cross sections. Thus, every interaction has its 
probability. The individual probabilistic events 
that comprise a process are simulated sequentially. 
The probability distributions governing these 
events are statistically sampled to describe the total 
phenomenon.  The statistical sampling process is 
based on the selection of random numbers. [6]
Description: a. right lobe b. left lobe c. diaphragms 
      d. bile
Figure 2. Liver Part diaphragm maintained to show the 
merging of the heart and diaphragm. Source: (Robins, 
2003)
Figure 2. is used for modeling the liver. 
Regional cancer network consists of Clinical 
Tumor Volume (CTV) and Planning Tumor 
Volume (PTV) and conducted modeling using 
mathematical equations. Cancer tissue waslocated 
in the right lobe. Interaction from neutron and 
matter in liver tissue could be calculated to several 
dose component. The component was obtain 
from recoil and photon. Interaction from fast or 
epithermal neutron and tissue matter was showed 
in Equation (3) (Rorer et al, 2001). 
                                     (3)
Dose from scattering interaction from fast 
and epithermal neutron with hydrogen would be 
calculated in this research as scattered neutron 
dose (Rorer et al, 2001).   
 
  (4)
 Gamma dose from Equation (4) would be 
calculated in this research as dose from thermal 
neutron and hydrogen reaction. 
Formula (1) explained interaction from 
thermal neutron and boron-10. Energy of 
alpha and lithium who produced by adsorption 
interaction was 2.33 MeV (Rorer et al, 2001). 
                 (5)
Dose from proton who produced from 
interaction from thermal neutron and nitrogen-
14 will be calculate based on Formula (5).
Dose in BNCT occurred belongs to neutron 
interaction to liver tissue. The interaction who 
take effect in dose calculation for this research 
was (Mika, 2002):
Boron reaction dose.1. 
Scattered neutron dose.2. 
Gamma dose.3. 
Proton dose.4. 
Formula who used for dose calculation in 
BNCT based on Equation (6).
                                                                     
(6)
remark: 
  : dose rate for boron interaction
  : biological weight factor for boron 
interaction
 :  dose rate for proton
 
ܪ ൅ ݊଴ଵ ื ݊ᇱ଴ଵ ൅ଵଵ ݌ଵଵ
ܪ ൅ ݊ሺͲǡͲͲʹͷܸ݁ሻ଴ଵ ՜ଵଵ ܦ ൅ ߛሺʹǡʹʹܯܸ݁ሻ଴ଵ
ܰ ൅ ݊଴ଵ଻ଵସ ሺͲǡͲͲʹͷܸ݁ሻ ՜ ܥ଺ଵସ ൅ ݌ଵଵ
ܦሶ௧௢௧௔௟ ൌ ൫ݓ஺௟௙௔ ൈ ܦሶ஺௟௙௔൯൅ ൫ݓ௣ ൈ ܦሶ௣௥௢௧௢௡൯൅ ൫ݓ௡ ൈ ܦሶ௡௘௨௧௥௢௡൯൅ ሺݓఊ ൈ ܦሶఊሻܦሶ௕௢௥௢௡
 
a b 
c 
d 
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 :  biological weight factor for 
proton 
  : dose rate for neutron
  : biological weight factor for neutron 
scattering 
  :  dose rate for gamma
  : biological weight factor for 
gamma
Monte Carlo method is a probabilistic 
approach to the possibility of interactions that 
will occur in radiation. Monte Carlo specify 
the desired value by performing simulations 
of each particle and noted that according to the 
characteristics of the particles and the medium 
through which it passes. Monte Carlo methods 
only show the information in accordance with 
the tally desired by the user (Thomas et al, 
2003). Derived from the neutron source reactor 
Kartini after passing a special collimator BNCT 
and have characteristics such as Table 1.
Based on Table 2, all of parameter who 
used in thermal column Kartini research reactor 
accepted from the IAEA Recommendation.  This 
study was conducted by doing simulations using 
Monte Carlo N-Particle eXtended (MCNPX) 
program. It works based on the probability of 
interactions between radiations and materials 
which is derived from the microscopic cross 
sections. The individual probabilistic events that 
comprise a process are simulated sequentially. 
The probability distributions governing these 
events are statistically sampled to describe the 
total phenomenon. The statistical sampling 
process is based on the selection of random 
numbers [7]. 
RESULT AND DISCUSION
Intended use of the thermal column because 
it already meets the IAEA recommendations on 
the use of BNCT facility neutron output. Liver 
is placed in the thermal column of the right lobe 
position in aperture collimator. Aperture used 
is 5 cm. The distance between the organ and 
the wall collimator 0.5 cm. Simulation heart 
is divided into four major sections. The outer 
part of the network consists of a healthy liver is 
composed of two lobes. Lobes modeled into two 
lobes, namely the right lobe and left lobe. Tumor 
tissue found on the right lobe. The second part 
of the volume of tissue called tumors planning 
(PTV). PTV has the same material with healthy 
tissue. The third part of a network called the 
clinical tumor volume (CTV). CTV has the 
characteristics of a material similar to the tumor 
due to the persistence of tumor infiltration of the 
tumor area. The density has the same value but 
the amount of tumor tissue distribution of boron 
in tumor tissue sections CTV half innermost 
part consists of cancerous tissue or could be 
Table 2. Beam Characteristic in BNCT Facility, Source: (Nina, 2013) 
Parameter Notation (Unit)
IAEA 
Recommendation
Result.
Epithermal neutron flux > 1,0 X 10
9
1,65  x 10 
9
Ratio of fast neutron dose rate and 
Epithermal neutron flux 
< 2.0 X 10 
-13
1,59 x 10
-13
Ratio of gamma dose rate and epithermal 
neutron flux
< 2,0 X 10
-13
1,16 x 10
-13
Ratio of thermal neutron flux and 
epithermal neutron flux
< 0,05 0,007
Ratio of neutron current and neutron flux > 0,7 0,72
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called gross tumor volume (GTV). This meets 
the tumor tissue sections with characteristics in 
accordance with plans including the number and 
density of boron. The amount of boron available 
in certain parts will affect the dose received.
Description:
Planning tumor volume (PTV)1. 
Clinical tumor volume (CTV)2. 
Cancer tissue/gross tumor volume (GTV)3. 
Figure 3. Frontal view of heart with the center point in 
the tumor mass.
Front piece depicts the shape of heart 
modeling based on Figure 2. Lobe of the right 
have larger sizes and there is a cancer in the lobe 
with a diameter of 5 cm.
Figure 4. Pieces addition to the liver with a central 
point in the tumor mass.
Side pieces of the organ showing the lines 
to divide each area at a specific depth  As per the 
available scale, depth of cancer found in 6 cm 
to 11 cm. Figures show the number of blue used 
surface and pink figures indicate cell numbers 
used in the modeling of the liver . In Figure 2, 
the modeling approach of the geometry of the 
heart from the front as listed in Figure 1. The 
right lobe, the left lobe and the bottom surface 
of the organ has been approached from the 
image geometry. Each section is divided into 
layers with the same thickness of 0.5 cm. Each 
layer of the neutron flux is analyzed and then 
the dose is calculated using the equation stated 
in method section. Dose rate of the layer that 
includes the area contained cancer is the focus in 
this study. Dose rate in tissue contained cancer 
tissue tumors are in the area and CTV
Figure 5. Distribution of neutron in liver tissue.
Figure 5 showed changed of neutron’s 
flux varied with liver depth. Peak of epithermal 
neutron flux’s was gotten in 1.5 cm and 
decreased after that. Peak of thermal neutron 
flux was obtained from 5 to 10 cm. 
Figure 6. Dose rate distribution in tissue
 
Description: 
3 
2 
1 
 
Figure 4. Pieces addition to the liver with a central point in the tumor mass.
5 cm 0 
Neutron 
direction  
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Figure 6 showed dose rate in irradiated 
tissue. Normal tissue was obtained from 0 until 
5 cm. Maximum dose was obtained in cancer 
tissue. Liver which suffered cancer from 6 to 
11 cm. 
Table 3. Dose Rate and Irradiating Time.
Concentration of B-10
(μg/g tumor tissue)
Dose rate in 
cancer (Gy/s)
Irradiating 
time(min)
20 0,042 19,911
25 0,050 16,661
30 0,058 14,312
35 0,067 12,397
40 0,074 11,253
45 0,082 10,141
47 0,085 9,763
Table 3 given the dose rate who accepted 
in cancer tissue. Dose rate can influence 
irradiating time. Irradiating time is gotten when 
dose in cancer tissue enough. Cancer need 50 
Gy to die. 
Table 4. Dose in Health tissue
Concentration of B-10
(μg/g tumor tissue)
Dose in Health Tissue 
(Gy)
20 5,875
25 5,016
30 4,306
35 3,735
40 3,393
45 3,075
47 2,950
Limit the dose used for liver tissue was 35 
Gy (Herman, 2009).  Dose received by healthy 
tissue by Table 4 which passes no dose limiting 
values  of healthy liver tissue. All concentration 
values  in Table 4 can be used for the irradiation 
of liver cancer.
As in the case of lung carcinoma, the study 
focused on lung (left lung) as shown in Figure 7. 
The number in red represents the number of cell 
cards in Visual Editor (VISED) which implies 
the organ where the doses were calculated.  As 
mentioned before, the radius of tumor is 3 cm 
and the tumor divided into 3 regions: the cell 
number 520 (pinkish region) is PTV which has 
the radius of 3 cm from the centre point, the 
cell number 521 (crème region) is CTV which 
has the radius of 2,5 cm while the cell number 
522 (turqoise region) is GTV with the radius 
of 2 cm. The tumour is located in the centre 
of the left lung whose depth from the surface 
(skin) is 6,5 to 8,8 cm. As seen, cell number 7 
represents skin, cell number 9 represents left 
lung, and cell number 29 represents rib cages, 
while cell number 54, 56, 58 and 60 represent 
the whole heart.
Figure 7. Thorax and lungs of the phantom with the 
tumour in anterior-posterior view.
 Moreover, neutron flux was being 
calculated in various depth of each cells which 
represent organs. The result was varied in 
relation with the depth of the cells with skin as 
the starting point. Figure 7. depicts the relation 
between neutron flux and the depth of the cells. 
The range of energy was defined in the study to 
differentiate the neutron flux; i.e. thermal and 
epithermal neutron flux. 
Figure 8. shows the neutron flux in the 
targeted organs. It appears that the neutron 
flux went smaller cm by cm because the flux 
interacted with components on the surface and 
had no much energy left when the neutron flux 
went deeper. The neutron flux hypothetically 
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was estimated to go smaller to avoid the damage 
of the cells in targeted organs, especially 
skin. In the surface; i.e. the depth of 0 cm, the 
epithermal neutron flux had a greater value than 
thermal neutron flux because fast neutron was 
moderated to become in the range of epithermal 
neutron. The number of thermal neutron flux 
was well below the epithermal neutron flux due 
to the energy possessed by thermal neutron had 
lessen during the process to the tissue. In the 
deeper depth, the decreasing of thermal neutron 
flux which was similar to epithermal neutron 
flux happened due to the scattering interaction 
with the spectra of tissue. The peak of f
epithermal
 
was 4,00×108 n.cm-2.sec-1. The result is logic 
and acceptable regarding to the neutron yield of 
the conceptual design of Compact DT Neutron 
Generator is similarly high as the outcome 
of nuclear research reactor; i.e. around 1×109 
n.cm-2.sec-1. The depth of PTV, CTV and GTV 
from skin consecutively are 6, 51 cm; 7, 08 cm 
and 8, 88 cm. The peak of thermal neutron flux 
is in the range of 1,5 to 2 cm. The result is logic 
and acceptable regarding to the neutron yield of 
the conceptual design of Compact DT Neutron 
Generator is similarly high as the outcome 
of nuclear research reactor; i.e. around 1×109 
n.cm-2.sec-1.
Figure 9. depicts the result of dose rate 
distribution in cells which the neutron radiation 
passing through and the amount of dose which 
produced and emitted in the certain duration 
of interaction with tissue. The radiation passed 
through skin, rib cages, healthy tissue of lungs 
to tumor tissue in lung. The peak of dose rate is 
in the depth range of 5,5 to 8,5 cm where tumor 
tissue which were divided in to three regions; i.e. 
PTV, CTV and GTV was located. In figure 9., 
it appears that the highest contribution of dose 
rate is the dose rate of alpha which was emitted 
in the interaction between boron-10 and thermal 
neutron in tissue. It was hypothetically expected 
because the solemnly desired contribution of 
dose in every BNCT treatment was the dose of 
alpha in tumor tissue.
Figure 10. As summary, distributions of total dose 
rates in concentrated tissue with varied concentrations 
of boron-10.
Figure 10. can be used as a comparison to 
figure 9. to ensure that the correlation between 
depth of the cells and dose rate is persisted 
Figure 8. Distribution of neutron flux in various depth 
of calculated cells.
Figure 9. Distribution of dose rate in targeted tissue 
with concentrated boron-10 of 25 µg.g-1 tissue.
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depending on the mass fractions of cells and 
the concentrations of boron-10. The boron-10 
concentration of 20 μg/g tumor tissue resulted 
in the total dose rate of 0,003145 Gy.sec-1, the 
concentration of 25 μg/g Gy.sec-1 tumor tissue 
resulted in the total dose rate of 0,003657 
Gy.sec-1, the concentration of 30 μg/g Gy.sec-1 
tumor tissue resulted in the total dose rate of 
0,00359 Gy. sec-1, the concentration of 35 μg/g 
Gy.sec-1 tumor tissue resulted in the total dose 
rate of 0,00385 Gy.sec-1, the concentration of 
40 μg/g tumor tissue resulted in the total dose 
rate of 0,00438 Gy.sec-1 while the boron-10 
concentration of 45 μg/g tumor tissue resulted 
in the total dose rate of 0,00476 Gy.sec-1.
Table 5. Dose rate and irradiation time.
Boron Concentration 
(μg.g-1 tissue)
Dose Rate 
(Gy.sec-1)
Irradiation 
Time (minute)
20 0,00223 375,34
25 0,00233 357,55
30 0,00291 287,58
35 0,00299 284,95
40 0,00352 237,84
45 0,00381 219,84
Table 5. depicts the data of variations in 
boron-10 concentration resulting in changing 
of dose rate in tissue (Gy.sec-1) and irradiation 
time needed (minute).
After gaining the value of dose rate, 
irradiation time can be obtained by substituting 
the number in the equation using spread sheet 
application. The total dose which needs to 
eradicate lung cancer cells is 50 Gy. Table 5. 
shows the relation between the dose rate and 
irradiation time. As showed, the dose rate 
had effects on irradiation time needed in the 
treatment to fulfill the desired dose in the tumor. 
Irradiation time has to ensure the duration 
of delivering the needed dose to combat and 
eradicate cancer cell.
Figure 11. depicts the result of the dose 
rate of varied amount of boron-10 concentration 
in concentrated tumor. As showed, the dose rate 
increased simultaneously with the increasing 
amount of boron-10 concentration in tissue.
In the opposite, figure 12 shows the 
relation between irradiation times needed in 
treatment with the varied amount of boron-
10 concentration in concentrated tumor. As 
showed, the irradiation time decreased with the 
increasing amount of boron-10 concentration in 
tissue. The range of irradiation time needed for 
treatment is from 219,84 to 375,34 minutes.
Figure 12. Irradiation time needed in treatment with 
the varied amount of boron-10 concentration in tumor
The boron-10 concentration of 20 μg/g 
tumor tissue resulted in irradiation time of 
375,34 minutes, the concentration of 25 μg/g 
Gy.sec-1 tumor tissue resulted in irradiation 
time of 357,55 minutes, the concentration of 30 
μg/g Gy.sec-1 tumor tissue resulted in irradiation 
time of 287,59 minutes, the concentration of 35 
μg/g Gy.sec-1 tumor tissue resulted in irradiation 
Figure 11. Dose rate in concentrated tumor tissue with 
varied Boron-10 concentration.
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time of 284,96 minutes, the concentration of 
40 μg/g tumor tissue resulted in irradiation 
time of 237,85 minutes while the boron-10 
concentration of 45 μg/g tumor tissue resulted 
in irradiation time of 219,840 minutes. As 
showed, irradiation time which need for the 
treatment decreased along with the increasing 
amount of boron-10 concentration in tumor 
tissue. Although the unit of time is quite long, 
in comparison with traditional therapies such as 
Co-60, the duration of lung carcinoma treatment 
by BNCT based on this simulation is far more 
convenient.
The reduction of irradiation time needed 
reflects the higher probability of interactions 
between boron-10 with cancer cell which emits 
alpha particle. The richer amount of boron-10, 
the higher possibility of interactions may occur 
in tissue.
While the tumor was being irradiated, 
it is not only the tumor region which will be 
exposed to the radiations, but all organs in 
the body will also be exposed too due to the 
secondary interactions. For consideration, it is 
an obligatory to calculate the dose rate and the 
amount of dose that may expose the other organs 
which are located near the targeted tumor. In 
this case, the organs at risk are skin, rib cages 
and heart. Every organ has its own Normal 
Tissue Tolerances, for skin, rib cages and heart 
respectively are 6 Gy, 6 Gy and 2,5 Gy. 
Skin has probability to have erythema, 
moist desquamation and ulceration as an effect 
if skin being exposed more than the allowed 
Normal Tissue Tolerances, while heart could 
have cardiomyopathy, damage in the valve and 
premature coronary artery disease once the dose 
exceed the Normal Tissue Tolerances. The result 
that was obtained from the equations showed 
that all variations of Boron-10 concentration 
results in that all organs at risk were still 
under their Normal Tissue Tolerances with the 
biggest value of all three were when the tumor 
was injected by 45 μg/g tissue with the dose 
were for skin, rib cages and heart respectively 
2,703 Gy, 1,636 Gy and 0,789 Gy. Although all 
variations of boron-10 concentration were still 
acceptable, the amount of boron-10 in the body 
must be limited due to the toxic effect that may 
be caused after the irradiation.
CONCLUSION
Maximum flux reached from 5 to 9 cm from • 
liver surface.
Irradiating time to kill cancer tissue from 9 • 
min 45 sec until 19 min 54 sec.
Maximum of boron-10 concentration for • 
liver tissue is 47 μg/g cancer tissue and need 
9 min 45 sec for therapy. 
The depth of tissue which has the most • 
optimum thermal neutron flux is located in 
the range of 1,5 to 2,0 cm from the surface; 
i.e. skin. In that range, thermal neutron flux 
has its peak,
Table 6. The dose rate of neutron radiation in healthy 
tissue and Organs at Risk (OAR).
Boron 
Concentration 
(µg.g-1 tissue)
Organ at 
Risk
Dose 
(Gy)
Normal Tissue 
Tolerances 
(Gy)
20 Skin 4,055 6
Rib 2,438 6
Heart 0,789 2,5
25 Skin 3,964 6
Rib 1,767 6
Heart 0,715 2,5
30 Skin 3,939 6
Rib 1,577 6
Heart 0,667 2,5
35 Skin 3,917 6
Rib 1,492 6
Heart 0,544 2,5
40 Skin 3,821 6
Rib 1,591 6
Heart 0,457 2,5
45 Skin 3,802 6
Rib 1,446 6
Heart 0,368 2,5
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Irradiation time needed to irradiate lung • 
carcinoma will decrease simultaneously 
with the increasing number of boron-10 
concentration in tumor. Irradiation time 
needed to combat and eradicate cancerous 
cell in this study is in the range of 219,840 
minutes to 375,342 minutes,
The most optimum number of boron-10 • 
concentration in this particular case is 45 
μg/g tumor tissue. With 45 μg/g tumor 
tissue, the optimum dose in the tumor is 
obtained while organs at risk were still kept 
under their Normal Tissue Tolerances.
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